Hirai H - Search Results

1

Task Force Paper On Cerebellar Transplantation: Are We Ready to Treat Cerebellar Disorders with Cell Therapy?

Cendelin J, Buffo A, Hirai H, Magrassi L, Mitoma H, Sherrard R, Vozeh F, Manto M. Cendelin J, et al. Among authors: hirai h. Cerebellum. 2019 Jun;18(3):575-592. doi: 10.1007/s12311-018-0999-1. Cerebellum. 2019. PMID: 30607797 Review.

2

Progress in transduction of cerebellar Purkinje cells in vivo using viral vectors.

Hirai H. Hirai H. Cerebellum. 2008;7(3):273-8. doi: 10.1007/s12311-008-0012-5. Cerebellum. 2008. PMID: 18418690 Review.

3

High transgene expression by lentiviral vectors causes maldevelopment of Purkinje cells in vivo.

Sawada Y, Kajiwara G, Iizuka A, Takayama K, Shuvaev AN, Koyama C, Hirai H. Sawada Y, et al. Among authors: hirai h. Cerebellum. 2010 Sep;9(3):291-302. doi: 10.1007/s12311-010-0161-1. Cerebellum. 2010. PMID: 20178014

4

Basic research on cerebellar gene therapy using lentiviral vectors.

Hirai H. Hirai H. Cerebellum. 2012 Jun;11(2):443-5. doi: 10.1007/s12311-011-0330-x. Cerebellum. 2012. PMID: 22120847 Review.

5

Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells.

Konno A, Shuvaev AN, Miyake N, Miyake K, Iizuka A, Matsuura S, Huda F, Nakamura K, Yanagi S, Shimada T, Hirai H. Konno A, et al. Among authors: hirai h. Cerebellum. 2014 Feb;13(1):29-41. doi: 10.1007/s12311-013-0516-5. Cerebellum. 2014. PMID: 23955261

6

Mesenchymal stem cells ameliorate cerebellar pathology in a mouse model of spinocerebellar ataxia type 1.

Matsuura S, Shuvaev AN, Iizuka A, Nakamura K, Hirai H. Matsuura S, et al. Among authors: hirai h. Cerebellum. 2014 Jun;13(3):323-30. doi: 10.1007/s12311-013-0536-1. Cerebellum. 2014. PMID: 24242763

7

Mesenchymal stem cells as a potential therapeutic tool for spinocerebellar ataxia.

Nakamura K, Mieda T, Suto N, Matsuura S, Hirai H. Nakamura K, et al. Among authors: hirai h. Cerebellum. 2015 Apr;14(2):165-70. doi: 10.1007/s12311-014-0604-1. Cerebellum. 2015. PMID: 25280585 Review.

8

Retrograde signaling for climbing fiber synapse elimination.

Uesaka N, Uchigashima M, Mikuni T, Hirai H, Watanabe M, Kano M. Uesaka N, et al. Among authors: hirai h. Cerebellum. 2015 Feb;14(1):4-7. doi: 10.1007/s12311-014-0615-y. Cerebellum. 2015. PMID: 25338972 Review.

9

Viral Vector-Based Evaluation of Regulatory Regions in the Neuron-Specific Enolase (NSE) Promoter in Mouse Cerebellum In Vivo.

Shinohara Y, Ohtani T, Konno A, Hirai H. Shinohara Y, et al. Among authors: hirai h. Cerebellum. 2017 Dec;16(5-6):913-922. doi: 10.1007/s12311-017-0866-5. Cerebellum. 2017. PMID: 28508170

10

Type 1 metabotropic glutamate receptor and its signaling molecules as therapeutic targets for the treatment of cerebellar disorders.

Hirai H, Kano M. Hirai H, et al. Curr Opin Pharmacol. 2018 Feb;38:51-58. doi: 10.1016/j.coph.2018.02.002. Epub 2018 Mar 8. Curr Opin Pharmacol. 2018. PMID: 29525719 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,856 results

Search Page

Filters